Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

MS Research Roundup: December 21, 2014
Histopathological comparison of Kearns-Sayre syndrome and PGC-1α-deficient mice suggests a novel concept for vacuole formation in mitochondrial encephalopathy.
Integrating genome-wide association studies and gene expression data highlights dysregulated multiple sclerosis risk pathways.
Persistence with Fingolimod Versus Dimethyl Fumarate in Patients with Multiple Sclerosis: Retrospective Analysis of us Open-Source Pharmacy Data.
Voxel Based Morphometry in Optical Coherence Tomography: Validation & Core Findings.
Characteristics of Patients with Relapsing Remitting Multiple Sclerosis Taking Injectable and Oral Disease Modifying Treatments in the United States.
Switching from natalizumab to fingolimod: an observational study.
Perspectives and experiences of Dutch multiple sclerosis patients and multiple sclerosis-specialized neurologists on injectable disease-modifying treatment.
American Society for Neurochemistry 2014
Long-term disability and prognostic factors in polyneuropathy associated with anti-myelin- associated glycoprotein (MAG) antibodies.
Regression-Based Norms for the Brief Visuospatial Memory Test-Revised in Italian population and application in MS patients.
MS Patient, Ph.D.: When Old Symptoms Resurface
Case Report of Lewis and Sumner Syndrome with Bilateral Vagus Nerves Paralysis for 16 Years.
Host cell virus entry mechanisms enhance anti-JCV-antibody switch in natalizumab-treated multiple sclerosis patients.
High-throughput platforms for the screening of new therapeutic targets for neurodegenerative diseases.
Unilateral Optic Neuritis: A Rare Complication after Measles-Mumps-Rubella Vaccination in a 30-Year-Old Woman.
ANNALS EXPRESS: Multiple Sclerosis: Assay of Free Immunoglobulin Light Chains.
Persistence in Open and Closed Data Sources: A Study of Fingolimod Verse Interferons/Glatiramer Acetate in Patients with Multiple Sclerosis.
Anti-JC virus seroprevalence in a Spanish multiple sclerosis cohort: JC virus seroprevalence in Spain.
Partnership and consent in MS treatment choice.
Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial.
Comparing Characteristics of Hungarian "Real Life" Patients With Participants of RCTS: First-Line Disease Modifying Therapies in Multiple Sclerosis.
Biogen Idec Becomes Biogen
Making Treatment & Lifestyle Decisions: Thinking About Benefits & Risks
Multimodal evoked potentials follow up in multiple sclerosis patients under fingolimod therapy.

Pages